login
Home / Papers / Economic analysis of the prevalence and clinical and economic burden...

Economic analysis of the prevalence and clinical and economic burden of medication error in England

368 Citations2020
Rachel Elliott, Elizabeth Camacho, Dina Janković

There is significant uncertainty around estimates due to the assumption that avoidable ADEs correspond to medication errors, data quality, and lack of data around longer-term impacts of errors.

Abstract

Ubiquitous medicines use in health care leads unsurprisingly to high numbers of medication errors, although most are not clinically important. There is significant uncertainty around estimates due to the assumption that avoidable ADEs correspond to medication errors, data quality, and lack of data around longer-term impacts of errors. Data linkage between errors and patient outcomes is essential to progress understanding in this area.